Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents

Journal of Pediatric Endocrinology and Metabolism

Volumn 26, Issue 11-12, 2013, Pages 1141-1147

  Arslan, Nur ^a   Tokgoz, Yavuz ^a   Kume, Tuncay ^a   Bulbul, Memduh ^a   Sayin, Oya ^a   Harmanci, Duygu ^a   Akdogan, Gul Guner ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Adipokine; Adolescents; Neopterin; Non alcoholic fatty liver disease; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; CHOLESTEROL; GHRELIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEOPTERIN; RESISTIN; TRIACYLGLYCEROL;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADOLESCENT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER FUNCTION TESTS; MALE; NEOPTERIN; OBESITY;

EID: 84888087022     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2013-0029     Document Type: Article

References (50)

1. Sinatra FR. Nonalcoholic fatty liver disease in pediatric patients. J Parenter Enteral Nutr 2012;36:43S-8S.
2. Arslan N, Buyukgebiz B, Ozturk Y, Cakmakci H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005;47:23-7.
3. Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012;9:152-61.
4. Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, et al. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2008;53:1352-7.
5. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009;204:521-5.
6. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008;63:423-7.
7. Demircioǧlu F, Kocyiǧit A, Arslan N, Cakmakci H, Hizli S, et al. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008;47:68-75.
8. Arslan N, Makay B. Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab 2010;23:807-13.
9. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-80.
10. Homann C, Benfield TL, Graudal NA, Garred P. Neopterin and interleukin-8-prognosis in alcohol-induced cirrhosis. Liver 2000;20:442-9.
11. Wilmer A, Nolchen B, Tilg H, Herold M, Pechlaner C, et al. Serum neopterin concentrations in chronic liver disease. Gut 1995;37:108-12.
12. Kalkan A, Ozden M, Akbulut H. Serum neopterin levels in patients with chronic hepatitis B. Jpn J Infect Dis 2005;58:107-9.
13. Demirturk N, Demirdal T, Aktepe OC, Aykin N, Orhan S, et al. Serum neopterin levels in patients with HBV infection at various stages. Hepatogastroenterology 2007;54:903-5.
14. Gulcan EM, Tirit I, Anil A, Adal E, Ozbay G. Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity. World J Gastroenterol 2008;14:6840-3.
15. Kilic D, Boyunaǧa H, Kaygusuz S, Akgul E, Al Rashed M, et al. Neopterin levels in nonreplicative HBV carriers. Hepatol Res 2002;24:18.
16. Schaefer CJ, Kossen K, Lim SR, Lin JH, Pan L, et al. Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 2011;55:3125-32.
17. Demirbas S, Cakir E, Akgul EO, Seyrek M, Cayci T, et al. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environ Toxicol Pharmacol 2011;31:165-70.
18. Strauss RS. Childhood obesity. Pediatr Clin North Am 2002;49:175-201.
19. Quin SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. Am J Roentgenol 1985;145:753-5.
20. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649-58.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
22. Flavall EA, Crone EM, Moore GA, Gieseg SP. Dissociation of neopterin and 7,8-dihydroneopterin from plasma components before HPLC analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2008;863:167-71.
23. Carru C, Zinellu A, Sotgia A, Serra R, Usai MF, et al. A new HPLC method for serum neopterin measurement and relationships with plasma thiols levels in healthy subjects. Biomed Chromatogr 2004;18:360-6.
24. Ledochowski M, Murr C, Widner B, Fuchs D. Association between insulin resistance, body mass and neopterin concentrations. Clin Chim Acta 1999;282:115-23.
25. Ursavas A, Karadag M, Oral AY, Demirdogen E, Oral HB, et al. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med 2008;102:1193-7.
26. Spencer ME, Jain A, Matteini A, Beamer BA, Wang NY, et al. Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci 2010;65:858-65.
27. Bozdemir AE, Barutcuoglu B, Dereli D, Kabaroglu C, Habif S, et al. C-reactive protein and neopterin levels in healthy non-obese adults. Clin Chem Lab Med 2006;44:317-21.
28. Oxenkrug G, Tucker KL, Requintina P, Summergrad P. Neopterin, a marker of interferon-gamma-inducible inflammation, correlates with pyridoxal-5'- phosphate, waist circumference, HDL-cholesterol, insulin resistance and mortality risk in adult Boston community dwellers of Puerto Rican origin. Am J Neuroprot Neuroregen 2011;3:48-52.
29. Rao VS, Nagaraj RK, Hebbagodi S, Kadarinarasimhiah NB, Kakkar VV. Association of inflammatory and oxidative stress markers with metabolic syndrome in Asian Indians in India. Cardiol Res Pract 2010;2011:295976.
30. Mangge H, Freytag F, Almer G, Weghuber D, Bauer-Denk C, et al. Serum neopterin is not increased in obese juveniles. J Obes 2011;2011:946795. doi: 10.1155/2011/946795. Epub 2011 Jan 12.
31. Kabaroǧlu C, Onur E, Barutcuoǧlu B, Ozhan B, Erdinc S, et al. Inflammatory marker levels in obese adolescents with glucose intolerance: increased chitotriosidase activity. Clin Biochem 2012;45:281-4.
32. Canas JA, Damaso L, Altomare A, Killen K, Hossain J, et al. Insulin resistance and adiposity in relation to serum ?-carotene levels. J Pediatr 2012;161:58-64.
33. Kelly AS, Metzig AM, Schwarzenberg SJ, Norris AL, Fox CK, et al. Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity. Metab Syndr Relat Disord 2012;10:123-7.
34. Pedrosa C, Oliveira BM, Albuquerque I, Simoes-Pereira C, Vaz-de-Almeida MD, et al. Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren. Diabetol Metab Syndr 2010;2:40.
35. Uygun A, Kadayifci A, Musabak U, Ercin N, Karslioglu Y, et al. Serum neopterin levels in patients with non-alcoholic steatohepatitis. Hepatol Res 2008;38:904-8.
36. Yaman H, Cakir E, Ozcan O, Yesilova Z, Ozcan A, et al. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem 2005;38:187-90.
37. Abdou AS, Magour GM, Mahmoud MM. Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity. Br J Biomed Sci 2009;66: 143-7.
38. Johnston, DT, Gagos M, Raio N, Ragolia L, Shenouda D, et al. Alterations in serum neopterin correlate with thrombolysis in myocardial infarction risk scores in acute coronary syndromes. Coron Artery Dis 2006;17:511-6.
39. Ray KK, Morrow DA, Sabatine S, Shui A, Rifai N, et al. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007;115:3071-8.
40. Adachi T, Naruko T, Itoh A, Komatsu R, Abe Y, et al. Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart 2007;93:1537- 41.
41. Kashi JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz-Fernandez JM, Garcia-Moll X, et al.; SIESTA Investigators. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-STsegment elevation acute coronary syndrome. Atherosclerosis 2008;201:176-83.
42. Alber HF, Duftner M, Wanitschek M, Dorler J, Schirmer M, et al. Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol 2009;135:27-35.
43. Videm V, Wiseth R, Gunnes S, Madsen HO, Garred P. Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol 2007;118:81-7.
44. Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 2009;55:1135-46.
45. Vengen IT, Dale AC, Wiseth R, Midthjell K, Videm V. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus. Long-term follow-up of the HUNT 1 study. Atherosclerosis 2009;207:239-44.
46. Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005;26:457-63.
47. Auer J, Berent R, Labnig E, Eber B. Serum neopterin and activity of coronary artery disease. Heart Dis 2001;3:297-301.
48. Hoffmann G, Schobersberger W, Frede S, Pelzer L, Fandrey J, et al. Neopterin activates transcription factor nuclear factor-B in vascular smooth muscle cells. FEBS Lett 1996;391: 181-4.
49. Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra- Sanchez L, et al. The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem 2009;16: 4644-53.
50. Hoffmann G, Kenn S, Wirleitner B, Deetjen C, Frede S, et al. Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Immunobiology 1998;199: 63-73.